Therefore, the most important observation to emerge from our study is that patients with higher preoperative serum NPY concentration, which is an orexigenic neuropeptide also favoring cancer growth and migration, had a greater probability of survival during the 1200 days after CRC surgery performed with curative intention (Figure 2). The gene discussed is NPS; the disease is cancer.